Piotr Jakubowski
Chief Executive Officer en COPERNICUS SECURITIES S.A. .
Perfil
Piotr Jakubowski is currently the Chairman of the Management Board at Copernicus Securities SA. He is also the Deputy Chairman of the Supervisory Board at Emmerson Realty SA since 2018.
Additionally, he serves as a Member of the Supervisory Board at Erne Ventures SA and is a Member of The Polish Society of Market & Opinion Researchers.
Mr. Jakubowski previously held positions as the Chairman of the Supervisory Board at Grupa Emmerson SA, a Member of the Supervisory Board at InteliWISE SA, and a Member of the Supervisory Board at B2BPartner SA. He obtained his undergraduate degree from the Warsaw School of Economics.
Cargos activos de Piotr Jakubowski
| Empresas | Cargo | Inicio |
|---|---|---|
| ERNE VENTURES SA | Director/Board Member | 21/07/2010 |
| EMMERSON REALTY S.A. | Director/Board Member | 24/12/2010 |
| COPERNICUS SECURITIES S.A. | Chief Executive Officer | - |
| The Polish Society of Market & Opinion Researchers | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Piotr Jakubowski.
| Empresas | Cargo | Fin |
|---|---|---|
| GRUPA EMMERSON S.A. | Chairman | - |
| B2BPARTNER SA | Director/Board Member | - |
| INTELIWISE S.A. | Director/Board Member | - |
Formación de Piotr Jakubowski.
| Warsaw School of Economics | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| INTELIWISE S.A. | Technology Services |
| COPERNICUS SECURITIES S.A. | Finance |
| B2BPARTNER SA | Commercial Services |
| EMMERSON REALTY S.A. | Finance |
| Empresas privadas | 3 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Grupa Emmerson SA
 Grupa Emmerson SA Real Estate DevelopmentFinance Grupa Emmerson SA provides real estate brokerage services. It provides property management and consulting services including cleaning, maintenance, repairs, and financial administration to commercial and residential developments as well as individuals. The company was founded by Marek Krajewski in 1994 and is headquartered in Warsaw, Poland. | Finance |
| The Polish Society of Market & Opinion Researchers |
- Bolsa de valores
- Insiders
- Piotr Jakubowski
